RESEARCH, PRODUCT FOCUS STUDIES & CLINICAL TRIAL EFFORTS

Principal Investigators, Clinical Coordinators, Researchers and other Industry professionals who wish to collaborate with the ERC or simply list their Trial or Study with us should contact AskERC@aol.com

Since we were founded, the ERC has and continues to routinely assist industry leaders with clinical research, developmental studies and data collection on the disease; lobbies in support of various research grants; and so much more.  The ERC has collaborated on several books, publications, and videos pertaining to the disease over the years, as well as working with the extended media to bring education and awareness to the forefront of society.  Additionally, the ERC was pleased to host the Internet’s first free Endometriosis educational webcast during our Symposium and workshops held at the ERC Conference at our nation’s capital in Washington, DC.

The ERC is actively involved in ongoing disease research, ranging from recruitment for clinical trials on proprietary new treatments to participation in genetic research studies for various biotech companies focused on the discovery of novel therapeutics and diagnostics to address significant unmet medical needs in Endometriosis. Currently, we are the trial coordinator for an emerging and novel, non-invasive diagnostic test with a leading biotech firm, and recently we closed an exciting product focus study on a non-invasive, symptomatic aid designed especially for those with Endometriosis.  We were the clinical partner in the A-Fem Medical pilot study conducted to validate the world’s first self-collection kit and testing method to attempt to provide a screening system for Endometriosis. The preliminary results were promising, particularly for undiagnosed women and adolescents, and this novel work has now become an area of focus for the global biotech community. In addition, the ERC has previously conducted our own study into a potential relationship between the use of Menstrual Cup devices and Endometriosis, in association with the esteemed President of Associated Pharmacologists & Toxicologists and Author of the prestigious ReproTox Database.  Our organization also performed a large product focus study involving the first unique, all-natural topical product designed specifically for menstrual cramping.  We have also previously conducted a study of medical professionals in collaboration with Agile Therapeutics, using data collection and analysis to determine the scientific formulation of a birth control patch compound.  Other collaborations include, but are not limited to, Amgen Praecis Corporation; EmerGEN; Neurocrine Bioscience; FemmePharma; the International OxeGENE Study Group; the National Women’s Health Information Center; The Office on Women’s Health/U.S. Department of Health & Human Services; Helica TC Corporation; Zonagen Corporation; and many, many others.

The ERC is an established member of the unified, global Endometriosis community.  We have the privilege of collaborating with world leaders on the disease and enjoy collaborative relationships with similar like-minded foundations, including the National Endometriosis Society (United Kingdom), Associazione Italiana Endometriosi (Italy), the Endometriosis SHE Trust (United Kingdom), the Endometriosis Care Centre of Australia (ECCA), and RESOLVE, the national infertility organization.  Additionally, the ERC is represented in the American Society of Reproductive Medicine, the World Endometriosis Research Foundation, the World Endometriosis Society, the International PAX Society, the National Pain Foundation, and the American Chronic Pain Association. The ERC is also a Founding Partner in the Society for Women's Health Research, a collaboration sponsored by the Alliance for Women in Clinical Research.  A cruelty-free charity, the ERC is also a member of the Physician’s Committee for Responsible Research “Humane Charity” Initiative and the Primate Freedom Project's "Moratorium on Primate Research."  The Guidestar Foundation, a Federal charity watchdog organization, formally recognizes our organization as a member in good standing.

If we can provide assistance to your own research efforts, please contact us today. Unlike similar foundations, we lend our collaborative services for free; asking only for tax-exempt, tax-deductible donations in any amount to help support our mission and keep our programs free for all those with this disease.  Please let us know how may be able to lend our backing to your important work, whether it be recruiting from our vast patient ranks, utilizing our extensive media contacts to target specific locations or topics to be covered in the health news, to provide research data and information to your team, and much, much more.  We will also gladly lend our consultancy to SBIR and NDA processes as appropriate and applicable.

Endometriosis affects a staggering 70+ million women and girls worldwide, and there is no definitive cure.  Research to date has been sorely lacking, does not investigate the pathogenesis of the disease, and is not cure-directed.  We think you will agree there exists an ever-growing role for diagnostics and a deeper understanding of all facets of Endometriosis, and as such, we are pleased to be able to lend our support your investigatory research and studies.

Researchers, industry professionals, graduate students, allied and professional health provider, and potential research partners should contact AskERC@aol.com